SYNOPSIS A method for the measurement of serum folic acid activity is described, which is a modification of previous methods.
used a modification of this method to measure the folic acid activity of serum. They found that patients with folic acid deficiency had lower levels of serum folic acid activity than normal subjects or patients with uncomplicated vitamin B12 deficiency.
Using the method of Baker et al. (1959) , we found a considerable overlap between the results in normal subjects and patients with folic acid deficiency. There was also a wide variation in results between different batches. The diagnostic value of the method as described by Baker et al. (1959) was therefore of limited value in our hands. It seemed likely that the labile folic acid material was being inadequately protected by the method as we were using it. We therefore studied the factors affecting the preservation of folic acid active material in serum with a view to improving the diagnostic value of the assay. The results of these studies are reported and a modified assay procedure is described.
MATERIALS AND METHODS

BASAL MEDIUM
A modification of the basal medium of Jukes (1955) was used (Table I) . A vitamin-free enzymatic casein hydrolysate was used in preference to acid hydrolysed casein (Difco, Oxoid) and salt-free hydrolysed casein (B.B.L.), because both of these preparations gave a precipitate after autoclaving which did not clear on cooling. When the enzymatic casein hydrolysate was used, additional tryptophane was found to be unnecessary. One batch of a 'dry-mix' medium (B.B.L. folic acid assay medium, special lot 009-607) containing a salt-free acid hydrolysate of casein was also tried. This also gave a precipitate after autoclaving. Nevertheless, it was otherwise satisfactory and would be a convenient medium if small numbers of sera are to be assayed.
This double-strength liquid basal medium was stable when stored in an amber bottle in the refrigerator.
MAINTENANCE OF THE STOCK CULTURE
The organism used was Lactobacillus casei (ATCC 7469.) This was maintained in dried gelatin discs (Stamp, 1947; Chanarin, Anderson, and Mollin, 1958) and stored in a desiccator over phosphorus pentoxide at room temperature.
Under these conditions the organism remained folic acid dependent and the growth in the control tubes, to which no folic acid was added, was less than 20% of the highest response in the standard tubes.
PREPARATION OF THE INOCULUM
A fresh gelatin disc containing the dried organisms was used for each assay. This was incubated in 10 ml. of Difco microinoculum broth for 30 hours at 37°C. The bacterial suspension was then centrifuged, the supematant decanted off, and the bacterial cells washed in 20 ml. of singlestrength basal medium. Finally, the cells were suspended in 20 ml. of single-strength basal medium to provide an inoculum of standard optical density (approximately 0-04). One drop of this inoculum was delivered to each assay tube with a Pasteur pipette (50 drops/ml.).
The inoculum was plated on a blood agar plate and incubated with the assay batch to detect any contaminants. COLLECTION Venous blood was collected from subjects at least two hours after food, and allowed to clot at room temperature for approximately two hours. Serum was separated, care being taken to prevent haemolysis, because it was found that varying degrees of haemolysis increased the folic acid activity from three to ten times that of unhaemolysed serum (unpublished observations). The serum was then stored at -20°C. until assayed.
STANDARD FOLIC ACID SOLUTION
A highly purified crystalline preparation of pteroylglutamic acid was used in preparing the standard curve for each assay, as described by Jukes (1955) . Because of the wide range of concentrations of folic acid used in preparing the standard solutions, special safeguards against contamination were taken. Volumetric flasks and pipettes were soaked in chromic-sulphuric fluid, thoroughly rinsed in tap water and finally in distilled water. Moreover, containers were marked and kept for the same concentration of folic acid.
DE-IONIZED WATER
500
An Elgastat de-ioniser (type B 107) with Elgalite mixedbed resin (C 403) was used with glass-distilled water. De-ionized water was used throughout for the preparation of medium and buffer and for the aqueous dilution of serum.
ASSAY PROCEDURE PREPARATION OF SERUM
Sera were prepared for assay by a modification of previous methods (Toennies et al., 1956; Baker et al., 1959) .
Sera were, however, diluted 1:10 with a 0 1 M. phosphate buffer ofpH 6-1. This buffer concentration has been shown to give the optimum yield of folic acid activity for L. casei (Dawbam, Hine, and Smith, 1958) . Various concentrations of ascorbic acid were used in the phosphate buffer (see results); the optimum concentration was found to be 100 mg. %. The tubes were then closed with aluminium caps, and autoclaved at 10 p.s.i. for 10 minutes, which provided safe sterilization for this assay. After cooling, one of the four tubes of each serum specimen was set aside as a blank, and the remaining tubes were placed at random in wooden test-tube racks and inoculated with one drop of the prepared inoculum of L. casei. The assay batch was then incubated at 37°C. ± I 'C. for 18 hours. STANDARD CURVE A standard curve was included in each assay. Tubes containing 0 0, 0-1, 0-2, 04, 0-6, 0-8, 10, 1-2, and 1-4 mpg.
of folic acid were set up in triplicate, as well as one uninoculated blank tube containing no folic acid (Jukes, 1955 The growth densities of the folic acid standards were plotted on arithmetic graph paper against the amount of folic acid per tube. A representative standard curve is shown in Fig. 1 . The most sensitive range of the curve is between 0-1 and 1 0 mjzg. per tube (0-025-025 m,ug./ml.), which corresponds to a range of serum folic acid activity from 2-0 to 20-0 mpg./ml., when a 1:80 dilution of the original serum is used. If the serum folic acid activity was lower than 2-0 mpg./ml. or greater than 20-0 m,ug./ml., the specimen was re-assayed at a lower or higher dilution to give readings on the sensitive part of the curve.
CARE OF GLASSWARE
Scrupulous care of glassware was essential to avoid folic acid contamination.
Test tubes were rinsed in tap water and boiled in a detergent (Pyroneg).1 They were then well rinsed with distilled water and packed into wire baskets to drain. All tubes were then filled with distilled water, autoclaved at 15 p.s.i. for 15 minutes, emptied, refilled with distilled water, and autoclaved again. The tubes were then dried, closed with aluminium caps, and sterilised at 160°C. for one hour. Aluminium caps were rinsed in tap water, boiled twice in distilled water, and then dried in a hot air oven.
Pipettes were allowed to stand in detergent and were then washed in running tap water overnight, rinsed through with distilled water, and dried with acetone.
IPyroneg is distributed by Deosan Ltd., 42-46 Weymouth Road, London, W. 1.
A. H. Waters and D. L. Mollin
Flasks, beakers, and measuring cylinders were cleaned with chromic-sulphuric fluid, washed well in running tap water, and finally rinsed with distilled water.
Glassware used in the assay may be kept under ultraviolet light, which results in the photolytic degradation of folic acid (Stokstad, Fordham, and de Grunigen, 1947; Toennies et al., 1953) .
SUBJECTS STUDIED
Serum folic acid activity was measured in the following groups of subjects: (1) One hundred normal subjects who were students or members of the staff of the Postgraduate Medical School of London; (2) 42 patients with untreated Addisonian pernicious anaemia, and nine patients with pernicious anaemia in remission following vitamin B,2 therapy; (3) 22 patients with megaloblastic anaemia of pregnancy and 16 normal pregnant women; (4) 15 patients with untreated idiopathic steatorrhoea, showing evidence of malabsorption with a typically abnormal jejunal biospy appearance; (5) seven patients with nutritional folic acid deficiency. This diagnosis was restricted to patients with a megaloblastic anaemia with a normal serum vitamin B,2 level, a poor dietary history, no history of taking anticonvulsant drugs, normal absorption of fat, glucose, folic acid, and B52, and no histological or radiological e idence of an intestinal lesion. The optical density readings at each PGA concentration level are given in Table 1I . The ascorbate buffer had no effect on the growth of the L. casei standards over the range of PGA concentrations used (0-0 25 mrg. per ml.). In the absence of ascorbic acid, serum folic acid activity ranged from 1-6 to 4-2 m,ug./ml. When ascorbic acid was added to the phosphate buffer the serum folic acid activity increased significantly. A constant level of serum folic acid activity was obtained when the ascorbic acid concentration in the buffer was 100 mg. %.
RESULTS
The importance of using the optimal concentration of ascorbic acid in the buffer is shown in 0-1 0-2 loss of folic acid activity during storage, there being no significant difference between the folic acid ormal subjects and six patients with activity of fresh and stored serum (0-4 > P > 0-3). iency were assayed with and without However, the added ascorbic acid had no effect on i the buffer. the folic acid activity of fresh serum (0-8 > P > 0-7). ice of ascorbic acid there was no Some sera were stored with higher concentrations rence (P > 0-4) between the levels of ascorbic acid. It was found that the protective rmal controls and cases of folic acid effect of ascorbic acid was the same with concentravever, when the optimum concentra-tions between 5 and 15 mg. per ml. of serum, but ic acid was used in the phosphate higher concentrations interfered with the preparawas a highly significant increase tion of sera for assay by lowering thepH and thereby Xthe serum folic acid activity of the preventing the coagulation of serum proteins during group, but no significant change autoclaving. (P > 0-6) in the serum folic acid activity of folic acid-deficient group. 9-7 ± 0-7 10-6 ± 1-2 10-3 ± 0-5 2-8 ± 0-2 7-4 ± 0-5 7-1 ±0-9 At the 5% level of significance, the maximum variation from the mean of two independent determinations on the same sample in the same assay was ± 16%, and in different assays ± 20%.
We have also shown that there is no significant day-to-day variation in the serum folic acid activity of the same subject. Sera collected from 26 subjects on two consecutive days were assayed in the same batch. The folic acid levels ranged from 2-0 to 25-0 m,ug./ml., and there was no significant difference between the duplicate samples in each case.
In less than 1 % of cases the variation between the folic acid activity of two consecutive daily serum samples from the same patient greatly exceeded the expected error of the method. In these cases this wide discrepancy between the results was due to exogenous PGA contamination. This was shown in two ways. The contaminated specimen was re-assayed, (a) using Streptococcus faecalis as the assay organism, which responds to PGA, but not to serum folic acid material; and (b) by the standard procedure for L. casei without adding ascorbic acid either to the fresh serum or to the phosphate buffer. Under these conditions serum folic acid activity is destroyed, whereas PGA is not.
SERUM FOLIC ACID ACTIVITY IN NORMAL SUBJECTS AND PATIENTS WITH MEGALOBLASTIC ANAEMIA
The folic acid activity of sera from normal subjects and patients with megaloblastic anaemia measured by this method are given in Table X . Each value recorded is the average of two independent assays on two samples taken on consecutive days. The levels of serum folic acid activity in normal subjects ranged from 5-9 to 21-0 mHg./ml. The levels in patients with megaloblastic anaemia due to folic acid deficiency associated with idiopathic steatorrhoea and nutritional folic acid deficiency were less than 3-5 m,g./ml.
There was no overlap between the levels obtained in cases of megaloblastic anaemia due to folic acid deficiency and those due to uncomplicated B12 deficiency. Of the 42 cases of untreated pernicious anaemia, only one had a folic acid level below the lower limit of the normal range. The folic acid level in this case was 4 0 m,ug./ml. and the serum B12 level 35 ,u,ug./ml. This patient failed to respond adequately to treatment with vitamin B12 alone and required folic acid as well for a full haematological response.
The mean serum folic acid activity in cases of untreated pernicious anaemia was significantly higher (P < 0001) than in normal subjects. The highest levels of all were found in eight cases of subacute combined degeneration of the cord with only minimal anaemia (range 144-36-8 m,ug./ml.; mean 24-8 m,g./ml. ± 2-4 m,tg./ml. S.E.). Following treatment with B12 the serum folic acid activity fell and there was no significant difference (0-4 > P > 0 3) between the levels of normal subjects and 'Euglena gracilis assay (Hutner, Bach, and Ross, 1956 ). cases of pernicious anaemia in remission following treatment with vitamin B12. The mean serum folic acid level in normal pregnant women was significantly higher (P < 0-001) than in normal control subjects and not significantly different from the mean level found in cases of untreated pernicious anaemia. In patients with severe megaloblastic anaemia of pregnancy the levels were as low as in cases of severe folic acid deficiency associated with idiopathic steatorrhoea and nutritional folic acid deficiency, but there were also some patients with levels between 4-0 and 7 0 m,ug./ml. The bone marrow in these cases was only slightly megaloblastic. However, Table X shows that the mean serum folic acid levels in both of these groups was well below the mean level found in normal pregnant women.
OTHER FACTORS AFFECTING SERUM L. CASEI ACTIVITY
The effect of antibiotics on serum L. casei activity was studied in three patients. Two of these patients had bronchopneumonia. One was being treated with tetracycline, 250 mg. q.i.d., when the serum sample was taken, and the other with procaine penicillin, 1 million units daily, and streptomycin, 0 5 g. b.d. The third patient, who had puerperal sepsis associated with megaloblastic anaemia, was being treated with chloramphenicol and neomycin, aa 250 mg. q.i.d. Moreover, this patient was also receiving pteroylglutamic acid, 25 mg. daily. Serum from the two patients receiving tetracycline and chloramphenicol and neomycin inhibited the growth of L. casei at a 1: 80 dilution, the latter despite the fact that the patient was receiving PGA simultaneously. However, serum from the patient receiving penicillin and streptomycin had an L. casei activity in the normal range (9 4 m,ug./ml.).
The effect of amethopterin was studied in a patient with acute leukaemia, who was being treated with 2-5 mg. of amethopterin on alternate days. Serum collected on the days that amethopterin was' given inhibited the growth of L. casei at a 1:80 dilution, whereas serum collected on the intervening days had a normal L. casei activity (6 m,ug./ml.).
DISCUSSION
The results given in this paper suggest that the difficulties we encountered using the assay described by Baker et al. (1959) were mainly due to (1) inadequate protection of the labile folic acid-like material during autoclaving and (2) loss ofthis material during storage. Our observations suggest that these losses can be prevented by increasing the amount of ascorbic acid in the phosphate buffer and by adding ascorbic acid to serum that is to be stored. When these precautions are taken the variation between the results in different assays is slight and there is a clearcut differentiation between the results in normal subjects and patients with megaloblastic anaemia requiring treatment with folic acid (Table X) .
PROTECTION OF LABILE FOLIC ACID MATERIAL DURING AUTOCLAVING
The importance of ascorbic acid and of other reducing agents for protecting labile folic acid activity of blood during assay has been emphasized by Toennies et al. (1956) . For this purpose they included 50 mg. % of ascorbic acid in their phosphate buffer and the same procedure was followed by Baker et al. (1959) in assaying serum. The results in Table III of this paper show that these amounts were inadequate for serum, but that the protection was complete when amounts of 100 mg. % or more were used. Herbert (1961) has also found it necessary to increase the concentration of ascorbic acid in the buffer. The role of ascorbic acid is uncertain. The added ascorbic acid presumably is required to protect the labile folic acid material during autoclaving (Toennies et al., 1956) . During this process ascorbic acid is also destroyed, but about 40 % remains so that the final concentration in each assay tube was about 0-1 mg. per ml. (Dawbarn et al., 1958; Waters and Mollin, 1961) . Herbert (1961) reports that ascorbic acid per se may stimulate the growth of L. casei in response to PGA. However, he studied the effect using much larger concentrations of folic acid than are used in the assay and with more ascorbic acid, for he did not autoclave the ascorbate-phosphate buffer before its addition to the assay tubes. The results of this paper suggest that under the conditions of the assay the concentrations of ascorbic acid used had no effect on the growth of L. casei. PROTECTION The nature of the stable and labile folic acid material in serum is unknown. Although blood contains a number of factors with folic acid activity, neither pteroylglutamic acid nor citrovorum factor are present (Usdin, 1959) .
The stable material resembles in certain respects pteroylglutamic acid, for it is active for L. casei, Strep. faecalis, and L. citrovorum, but other folic acid compounds and nucleotides also have similar characteristics. Furthermore, the fact that the concentrations of stable material in the serum of patients with pernicious anaemia and folic acid deficiency are similar to those found in normal subjects suggests that it is unlikely that this material is pteroylglutamic acid.
The labile folic acid factor resembles in some respects a precursor of citrovorum factor. It has been shown that ascorbic acid protects a labile precursor of folinic acid which appears in urine after the ingestion of folic acid (Silverman, Ebaugh, and Gardiner, 1956 ). However, the labile component in serum is not converted into folinic acid by autoclaving in the presence of ascorbic acid, because the folic acid material in serum has very little growth activity for Leuconostoc citrovorum (Pedicoccus cerevisiae) or Streptococcus faecalis (Toennies et al., 1953; Usdin, 1959; Herbert, 1961; Waters and Mollin, unpublished observations) , and Baker et al. (1959) and Herbert (1961) have suggested that it may well be a polyglutamate.
The significance of the increase in labile L. casei active material in untreated Addisonian pernicious anaemia and normal pregnant women is uncertain. The material presumably accumulates either because it is formed in excessive amounts in these patients or because there is a defect in its utilization. This observation is particularly interesting in view of the fact that injected pteroylglutamic acid is removed more rapidly from the plasma of patients with severe untreated pernicious anaemia than from normal subjects (Chanarin, Mollin, and Anderson, 1958) . It was also found by Chanarin, MacGibbon, O'Sullivan, and Mollin (1959) that the mean plasma clearance of injected pteroylglutamic acid was more rapid in normal pregnant women than in normal control subjects.
OTHER MODIFICATIONS OF THE ASSAY PROCEDURE
The method described differs in certain other respects from that described by Baker et al. (1959) .
1 Enzymatic casein hydrolysate is used instead of salt-free acid hydrolysed casein. This was used because with acid hydrolysed casein some precipitation occurred in the medium during autoclaving and this led to a high blank reading. A similar precipitation was observed with B.B.L. 'dry-mix' medium which, however, was otherwise very satisfactory.
2 The final volume in each assay tube was reduced from 10 ml. to 4 ml., and a final serum dilution of 1/80 was used. As a result of these changes only 0-5 ml. of serum was required for the assay and the range of serum folic acid activity that could be measured accurately was 2-0 to 20-0 mpg./ml., compared with 3 0 to 30-0 m,ug./ml. by the method of Baker et al. (1959) , who used a final serum dilution of 1/100. Cooperman, Luhby, and Avery (1960) have recently described a method of assay with L. casei in which the assay volume was reduced to 2 ml.; however, the overall sensitivity of this method was reduced by the very high serum dilutions which they used (1/250 to 1/1,000); the lower limit of serum folic acid activity that could be measured accurately at their lowest dilution being 3-75 m,ug./ml.
3 INCUBATION BEFORE ASSAY In the method described by Toennies et al. (1956) blood, after dilution with the ascorbate-phosphate buffer (50 mg. % ascorbic acid), was incubated for 90 minutes at 38°C. before autoclaving, and this procedure was followed by Baker et al. (1959) . This was found to be unnecessary if the serum was assayed within 48 hours of collection or if it had been stored with added ascorbic acid or if the lost folic acid activity of stored serum was restored by the addition of relatively large amounts of ascorbic acid. Herbert (1961) also found that incubation of the serum-ascorbic acid-buffer solution did not increase the folic acid activity of (presumably) fresh serum.
CLINICAL VALUE OF THE ASSAY
The results in Table X confirm the claim of Baker et al. (1959) and of Herbert, Baker, Frank, Pasher, Sobotka, and Wasserman (1960) that the L. casei assay is a valuable means of differentiating patients with megaloblastic anaemia requiring treatment with folic acid from patients with vitamin B12 deficiency. In patients with megaloblastic anaemia due to idiopathic steatorrhoea or dietary folic acid deficiency, the concentrations were invariably below the normal range. Similar results were also found in patients with severe to moderate megaloblastic anaemia of pregnancy. However, borderline levels were found in some patients with moderate to mild megaloblastic anaemia of pregnancy, but these were
